pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-274Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL GUIDELINESНовая классификация идиопатических интерстициальных пневмоний: совместный документ Американского торакального и Европейского респираторного обществNovel classification of idiopathic interstitial pneumonias: statement of American Thoracic Society / European Respiratory SocietyРедакционнаястатья20132810201305924Copyright © Редакционная с., 20132013Редакционная с.Редакционная с.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/274

По материалам: Travis W.D., Costabel U., Hansell D.M. et al. An official American Thoracic Society / European Respiratory Society Statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013, 188 (6): 733–748.

По материалам: Travis W.D., Costabel U., Hansell D.M. et al. An official American Thoracic Society / European Respiratory Society Statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013, 188 (6): 733–748.

идиопатические интерстициальные пневмонииобычная интерстициальная пневмониянеспецифическая интерстициальная пневмонияреспираторный бронхиолитдесквамативная интерстициальная пневмониякриптогенная организующаяся пневмонияострая интерстициальнаяidiopathic interstitial pneumoniausual interstitial pneumonianonspecific interstitial pneumoniarespiratory bronchiolitisdesquamative interstitial pneumoniacryptogenic organizing pneumoniaacute interstitial pneumonialymphoid interstitial pneuReferencesAmerican Thoracic Society, European Respiratory Society. American Thoracic Society / European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277–304.American Thoracic Society, European Respiratory Society. American Thoracic Society / European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277–304.Travis W.D., Hunninghake G., King T.E. et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338–1347.Travis W.D., Hunninghake G., King T.E. et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338–1347.Aziz Z.A., Wells A.U., Hansell D.M. et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59: 506–511.Aziz Z.A., Wells A.U., Hansell D.M. et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59: 506–511.Flaherty K.R., King T.E. Jr, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170: 904–910.Flaherty K.R., King T.E. Jr, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170: 904–910.Nicholson A.G., Addis B.J., Bharucha H. et al. Interobserver variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500–505.Nicholson A.G., Addis B.J., Bharucha H. et al. Interobserver variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500–505.Thomeer M., Demedts M., Behr J. et al. Idiopathic Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 31: 585–591.Thomeer M., Demedts M., Behr J. et al. Idiopathic Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 31: 585–591.Flaherty K.R., Andrei A.&C., King T.E. et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007; 175: 1054–1060.Flaherty K.R., Andrei A.&C., King T.E. et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007; 175: 1054–1060.Raghu G., Collard H.R., Egan J.J.et al. An official ATS / ERS / JRS / ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.Raghu G., Collard H.R., Egan J.J.et al. An official ATS / ERS / JRS / ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin. Chest Med. 2004; 25: 531–547, vi.Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin. Chest Med. 2004; 25: 531–547, vi.Lynch D.A., Newell J.D., Logan P.M. et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? Am. J. Roentgenol. 1995; 165: 807–811.Lynch D.A., Newell J.D., Logan P.M. et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? Am. J. Roentgenol. 1995; 165: 807–811.Silva C.I., Churg A., Muller N.L. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. Am. J. Roentgenol. 2007; 188: 334–344.Silva C.I., Churg A., Muller N.L. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. Am. J. Roentgenol. 2007; 188: 334–344.Silva C.I.S., Muller N.L., Lynch D.A. et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288–297.Silva C.I.S., Muller N.L., Lynch D.A. et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288–297.Akashi T., Takemura T., Ando N. et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am. J. Clin. Pathol. 2009; 131: 405–415.Akashi T., Takemura T., Ando N. et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am. J. Clin. Pathol. 2009; 131: 405–415.Churg A., Muller N.L., Flint J., Wright J.L. Chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2006; 30: 201–208.Churg A., Muller N.L., Flint J., Wright J.L. Chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2006; 30: 201–208.Churg A., Sin D.D., Everett D. et al. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2009; 33: 1765–1770.Churg A., Sin D.D., Everett D. et al. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2009; 33: 1765–1770.Fenton M.E., Cockcroft D.W., Wright J.L., Churg A. Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann. Allergy Asthma Immunol. 2007; 99: 465–466.Fenton M.E., Cockcroft D.W., Wright J.L., Churg A. Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann. Allergy Asthma Immunol. 2007; 99: 465–466.Sahin H., Brown K.K., Curran&Everett D. et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 2007; 244: 591–598.Sahin H., Brown K.K., Curran&Everett D. et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 2007; 244: 591–598.Hanak V., Golbin J.M., Ryu J.H. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin. Proc. 2007; 82: 812–816.Hanak V., Golbin J.M., Ryu J.H. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin. Proc. 2007; 82: 812–816.Felicio C.H., Parra E.R., Capelozzi V.L. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung 2007; 185: 39–46.Felicio C.H., Parra E.R., Capelozzi V.L. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung 2007; 185: 39–46.Park J.H., Kim D.S., Park I.N. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 2007; 175: 705–711.Park J.H., Kim D.S., Park I.N. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 2007; 175: 705–711.Hwang J.&H., Misumi S., Sahin H. et al. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J. Comput. Assist. Tomogr. 2009; 33: 410–415.Hwang J.&H., Misumi S., Sahin H. et al. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J. Comput. Assist. Tomogr. 2009; 33: 410–415.Song J.W., Do K.&H., Kim M.&Y. et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease–related usual interstitial pneumonia. Chest 2009; 136: 23–30.Song J.W., Do K.&H., Kim M.&Y. et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease–related usual interstitial pneumonia. Chest 2009; 136: 23–30.Corte T.J., Copley S.J., Desai S.R. et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J. 2012; 39: 661–668.Corte T.J., Copley S.J., Desai S.R. et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J. 2012; 39: 661–668.Suda T., Kono M., Nakamura Y. et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir. Med. 2010; 104: 1527–1534.Suda T., Kono M., Nakamura Y. et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir. Med. 2010; 104: 1527–1534.Kinder B.W., Collard H.R., Koth L. et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am. J. Respir. Crit. Care Med. 2007; 176: 691–697.Kinder B.W., Collard H.R., Koth L. et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am. J. Respir. Crit. Care Med. 2007; 176: 691–697.Garcia&Sancho C., Buendia&Roldan I., Fernandez&Plata M.R. et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir. Med. 2011; 105: 1902–1907.Garcia&Sancho C., Buendia&Roldan I., Fernandez&Plata M.R. et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir. Med. 2011; 105: 1902–1907.Hodgson U., Laitinen T., Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338–342.Hodgson U., Laitinen T., Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338–342.Marshall R.P., Puddicombe A., Cookson W.O., Laurent G.J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143–146.Marshall R.P., Puddicombe A., Cookson W.O., Laurent G.J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143–146.Barlo N.P., van Moorsel C.H.M., Ruven H.J.T. et al. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2009; 26: 155–161.Barlo N.P., van Moorsel C.H.M., Ruven H.J.T. et al. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2009; 26: 155–161.Nogee L.M., Dunbar A.E. III, Wert S.E. et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 2001; 344: 573–579.Nogee L.M., Dunbar A.E. III, Wert S.E. et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 2001; 344: 573–579.Kirwan M., Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim. Biophys. Acta 2009; 1792: 371–379.Kirwan M., Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim. Biophys. Acta 2009; 1792: 371–379.van Moorsel C.H., van Oosterhout M.F., Barlo N.P. et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am. J. Respir. Crit. Care Med. 2010; 182: 1419–1425.van Moorsel C.H., van Oosterhout M.F., Barlo N.P. et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am. J. Respir. Crit. Care Med. 2010; 182: 1419–1425.Alder J.K., Chen J.J.L., Lancaster L. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 2008; 105: 13051–13056.Alder J.K., Chen J.J.L., Lancaster L. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 2008; 105: 13051–13056.Cronkhite J.T., Xing C., Raghu G. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729–737.Cronkhite J.T., Xing C., Raghu G. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729–737.Lawson W.E., Crossno P.F., Polosukhin V.V. et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 2008; 294: L1119–L1126.Lawson W.E., Crossno P.F., Polosukhin V.V. et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 2008; 294: L1119–L1126.Seibold M.A., Wise A.L., Speer M.C. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1503–1512.Seibold M.A., Wise A.L., Speer M.C. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1503–1512.Zhang Y., Noth I., Garcia J.G., Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1576–1577.Zhang Y., Noth I., Garcia J.G., Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1576–1577.Lawson W.E., Loyd J.E., Degryse A.L. Genetics in pulmonary fibrosis – familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011; 341: 439–443.Lawson W.E., Loyd J.E., Degryse A.L. Genetics in pulmonary fibrosis – familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011; 341: 439–443.Monaghan H., Wells A.U., Colby T.V. et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125: 522–526.Monaghan H., Wells A.U., Colby T.V. et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125: 522–526.Ryu J.H., Colby T.V., Hartman T.E., Vassallo R. Smokingrelated interstitial lung diseases: a concise review. Eur. Respir. J. 2001; 17: 122–132.Ryu J.H., Colby T.V., Hartman T.E., Vassallo R. Smokingrelated interstitial lung diseases: a concise review. Eur. Respir. J. 2001; 17: 122–132.Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin. Chest Med. 2000; 21: 11–35, vii.Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin. Chest Med. 2000; 21: 11–35, vii.Vassallo R., Jensen E.A., Colby T.V. et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199–1205.Vassallo R., Jensen E.A., Colby T.V. et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199–1205.Cottin V., Le Pavec J., Prevot G. et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35: 105–111.Cottin V., Le Pavec J., Prevot G. et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35: 105–111.Cottin V., Cordier J.F. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136: 1–2.Cottin V., Cordier J.F. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136: 1–2.Cottin V., Nunes H., Brillet P.Y. et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586–593.Cottin V., Nunes H., Brillet P.Y. et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586–593.Mejia M., Carrillo G., Rojas&Serrano J. et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10–15.Mejia M., Carrillo G., Rojas&Serrano J. et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10–15.Akira M., Inoue Y., Kitaichi M. et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251: 271–279.Akira M., Inoue Y., Kitaichi M. et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251: 271–279.Flaherty K.R., Travis W.D., Colby T.V. et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2001; 164: 1722–1727.Flaherty K.R., Travis W.D., Colby T.V. et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2001; 164: 1722–1727.Flaherty K.R., Thwaite E.L., Kazerooni E.A. et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143–148.Flaherty K.R., Thwaite E.L., Kazerooni E.A. et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143–148.Sverzellati N., Wells A.U., Tomassetti S. et al. Biopsyproved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology 2010; 254: 957–964.Sverzellati N., Wells A.U., Tomassetti S. et al. Biopsyproved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology 2010; 254: 957–964.Sumikawa H., Johkoh T., Colby T.V. et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177: 433–439.Sumikawa H., Johkoh T., Colby T.V. et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177: 433–439.Silva C.I., Muller N.L., Hansell D.M. et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247: 251–259.Silva C.I., Muller N.L., Hansell D.M. et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247: 251–259.Lynch D.A., Godwin J.D., Safrin S. et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172: 488–493.Lynch D.A., Godwin J.D., Safrin S. et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172: 488–493.Kim E.Y., Lee K.S., Chung M.P. et al. Nonspecific interstitial pneumonia with fibrosis: serial highresolution CT findings with functional correlation. Am. J. Roentgenol. 1999; 173: 949–953.Kim E.Y., Lee K.S., Chung M.P. et al. Nonspecific interstitial pneumonia with fibrosis: serial highresolution CT findings with functional correlation. Am. J. Roentgenol. 1999; 173: 949–953.Hartman T.E., Swensen S.J., Hansell D.M. et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217: 701–705. [Published erratum appears in Radiology 218: 606.]Hartman T.E., Swensen S.J., Hansell D.M. et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217: 701–705. [Published erratum appears in Radiology 218: 606.]Park J.S., Lee K.S., Kim J.S. et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645–648.Park J.S., Lee K.S., Kim J.S. et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645–648.Cottin V., Donsbeck A.V., Revel D. et al. Nonspecific interstitial pneumonia: individualization of a clinicopathologic entity in a series of 12 patients. Am. J. Respir. Crit. Care Med.1998; 158: 1286–1293.Cottin V., Donsbeck A.V., Revel D. et al. Nonspecific interstitial pneumonia: individualization of a clinicopathologic entity in a series of 12 patients. Am. J. Respir. Crit. Care Med.1998; 158: 1286–1293.Nagai S., Kitaichi M., Itoh H. et al. Idiopathic nonspecific interstitial pneumonia / fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 1998; 12: 1010–1019.Nagai S., Kitaichi M., Itoh H. et al. Idiopathic nonspecific interstitial pneumonia / fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 1998; 12: 1010–1019.Johkoh T., Muller N.L., Colby T.V. et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225: 199–204.Johkoh T., Muller N.L., Colby T.V. et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225: 199–204.Johkoh T., Muller N.L., Cartier Y. et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555–560.Johkoh T., Muller N.L., Cartier Y. et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555–560.Nishiyama O., Kondoh Y., Taniguchi H. et al. Serial high resolution CT findings in nonspecific interstitial pneumonia / fibrosis. J. Comput. Assist. Tomogr. 2000; 24: 41–46.Nishiyama O., Kondoh Y., Taniguchi H. et al. Serial high resolution CT findings in nonspecific interstitial pneumonia / fibrosis. J. Comput. Assist. Tomogr. 2000; 24: 41–46.MacDonald S.L., Rubens M.B., Hansell D.M. et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600–605.MacDonald S.L., Rubens M.B., Hansell D.M. et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600–605.Akira M., Inoue Y., Arai T. et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66: 61–65.Akira M., Inoue Y., Arai T. et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66: 61–65.Katzenstein A.L., Fiorelli R.F. Nonspecific interstitial pneumonia / fibrosis: histologic features and clinical significance. Am. J. Surg. Pathol. 1994; 18: 136–147.Katzenstein A.L., Fiorelli R.F. Nonspecific interstitial pneumonia / fibrosis: histologic features and clinical significance. Am. J. Surg. Pathol. 1994; 18: 136–147.Travis W.D., Matsui K., Moss J., Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000; 24: 19–33.Travis W.D., Matsui K., Moss J., Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000; 24: 19–33.Tsubamoto M., Muller N.L., Johkoh T. et al. Pathologic subgroups of nonspecific interstitial pneumonia: differential diagnosis from other idiopathic interstitial pneumonias on high-resolution computed tomography. J. Comput. Assist. Tomogr. 2005; 29: 793–800.Tsubamoto M., Muller N.L., Johkoh T. et al. Pathologic subgroups of nonspecific interstitial pneumonia: differential diagnosis from other idiopathic interstitial pneumonias on high-resolution computed tomography. J. Comput. Assist. Tomogr. 2005; 29: 793–800.Park I.N., Jegal Y., Kim D.S. et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur. Respir. J. 2009; 33: 68–76.Park I.N., Jegal Y., Kim D.S. et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur. Respir. J. 2009; 33: 68–76.Hidalgo A., Franquet T., Gimenez A. et al. Smoking-related interstitial lung diseases: radiologic–pathologic correlation. Eur. Radiol. 2006; 16: 2463–2470.Hidalgo A., Franquet T., Gimenez A. et al. Smoking-related interstitial lung diseases: radiologic–pathologic correlation. Eur. Radiol. 2006; 16: 2463–2470.Craig P.J., Wells A.U., Doffman S. et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45: 275–282.Craig P.J., Wells A.U., Doffman S. et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45: 275–282.Fraig M., Shreesha U., Savici D., Katzenstein A.L. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am. J. Surg. Pathol. 2002; 26: 647–653.Fraig M., Shreesha U., Savici D., Katzenstein A.L. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am. J. Surg. Pathol. 2002; 26: 647–653.Vassallo R., Ryu J.H. Tobacco smoke-related diffuse lung diseases. Semin. Respir. Crit. Care Med. 2008; 29: 643–650.Vassallo R., Ryu J.H. Tobacco smoke-related diffuse lung diseases. Semin. Respir. Crit. Care Med. 2008; 29: 643–650.Portnoy J., Veraldi K.L., Schwarz M.I. et al. Respiratory bronchiolitisinterstitial lung disease: long-term outcome. Chest 2007; 131: 664–671.Portnoy J., Veraldi K.L., Schwarz M.I. et al. Respiratory bronchiolitisinterstitial lung disease: long-term outcome. Chest 2007; 131: 664–671.Doan M.L., Guillerman R.P., Dishop M.K. et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366–373.Doan M.L., Guillerman R.P., Dishop M.K. et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366–373.Bullard J.E., Wert S.E., Whitsett J.A. et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 2005; 172: 1026–1031.Bullard J.E., Wert S.E., Whitsett J.A. et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 2005; 172: 1026–1031.Kawabata Y., Hoshi E., Murai K. et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707–714.Kawabata Y., Hoshi E., Murai K. et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707–714.Katzenstein A.L., Mukhopadhyay S., Zanardi C., Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41: 316–325.Katzenstein A.L., Mukhopadhyay S., Zanardi C., Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41: 316–325.Snider G.L., Kleinerman J., Thurlbeck W.M., Bengali Z.H. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am. Rev. Respir. Dis.1985; 132: 182–185.Snider G.L., Kleinerman J., Thurlbeck W.M., Bengali Z.H. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am. Rev. Respir. Dis.1985; 132: 182–185.King T.E., Mortenson R. Cryptogenic organizing pneumonitis: the North American experience. Chest 1992; 102(1, Suppl): 8S–13S.King T.E., Mortenson R. Cryptogenic organizing pneumonitis: the North American experience. Chest 1992; 102(1, Suppl): 8S–13S.Lee J.W., Lee K.S., Lee H.Y. et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. Am. J. Roentgenol. 2010; 195: 916–922.Lee J.W., Lee K.S., Lee H.Y. et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. Am. J. Roentgenol. 2010; 195: 916–922.Sen T., Udwadia Z.F. Cryptogenic organizing pneumonia: clinical profile in a series of 34 admitted patients in a hospital in India. J. Assoc. Physicians India 2008; 56: 229–232.Sen T., Udwadia Z.F. Cryptogenic organizing pneumonia: clinical profile in a series of 34 admitted patients in a hospital in India. J. Assoc. Physicians India 2008; 56: 229–232.Oymak F.S., Demirbas H.M., Mavili E. et al. Bronchiolitis obliterans organizing pneumonia: clinical and roentgenological features in 26 cases. Respiration 2005; 72: 254–262.Oymak F.S., Demirbas H.M., Mavili E. et al. Bronchiolitis obliterans organizing pneumonia: clinical and roentgenological features in 26 cases. Respiration 2005; 72: 254–262.Lee J.S., Lynch D.A., Sharma S. et al. Organizing pneumonia: prognostic implication of high-resolution computed tomography features. J. Comput. Assist. Tomogr. 2003; 27: 260–265.Lee J.S., Lynch D.A., Sharma S. et al. Organizing pneumonia: prognostic implication of high-resolution computed tomography features. J. Comput. Assist. Tomogr. 2003; 27: 260–265.Lee K.S., Kullnig P., Hartman T.E., Muller N.L. Cryptogenic organizing pneumonia: CT findings in 43 patients. Am. J. Roentgenol. 1994; 162: 543–546.Lee K.S., Kullnig P., Hartman T.E., Muller N.L. Cryptogenic organizing pneumonia: CT findings in 43 patients. Am. J. Roentgenol. 1994; 162: 543–546.Muller N.L., Staples C.A., Miller R.R. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. Am. J. Roentgenol. 1990; 154: 983–987.Muller N.L., Staples C.A., Miller R.R. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. Am. J. Roentgenol. 1990; 154: 983–987.Ujita M., Renzoni E.A., Veeraraghavan S. et al. Organizing pneumonia: perilobular pattern at thin–section CT. Radiology 2004; 232: 757–761.Ujita M., Renzoni E.A., Veeraraghavan S. et al. Organizing pneumonia: perilobular pattern at thin–section CT. Radiology 2004; 232: 757–761.Kim S.J., Lee K.S., Ryu Y.H. et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am. J. Roentgenol. 2003; 180: 1251–1254.Kim S.J., Lee K.S., Ryu Y.H. et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am. J. Roentgenol. 2003; 180: 1251–1254.Epler G.R., Colby T.V., McLoud T.C. et al. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 1985; 312: 152–158.Epler G.R., Colby T.V., McLoud T.C. et al. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 1985; 312: 152–158.Lohr R.H., Boland B.J., Douglas W.W. et al. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch. Intern. Med. 1997; 157: 1323–1329.Lohr R.H., Boland B.J., Douglas W.W. et al. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch. Intern. Med. 1997; 157: 1323–1329.Lazor R., Vandevenne A., Pelletier A. et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am. J. Respir. Crit. Care Med. 2000; 162: 571–577.Lazor R., Vandevenne A., Pelletier A. et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am. J. Respir. Crit. Care Med. 2000; 162: 571–577.Fischer A., Swigris J.J., du Bois R.M. et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir. Med. 2009; 103: 1719–1724.Fischer A., Swigris J.J., du Bois R.M. et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir. Med. 2009; 103: 1719–1724.Bouros D., Nicholson A.C., Polychronopoulos V., du Bois R.M. Acute interstitial pneumonia. Eur. Respir. J. 2000; 15: 412–418.Bouros D., Nicholson A.C., Polychronopoulos V., du Bois R.M. Acute interstitial pneumonia. Eur. Respir. J. 2000; 15: 412–418.Vourlekis J.S., Brown K.K., Cool C.D. et al. Acute interstitial pneumonitis: case series and review of the literature. Medicine (Baltimore) 2000; 79: 369–378.Vourlekis J.S., Brown K.K., Cool C.D. et al. Acute interstitial pneumonitis: case series and review of the literature. Medicine (Baltimore) 2000; 79: 369–378.Ichikado K., Suga M., Muller N.L. et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am. J. Respir. Crit. Care Med. 2002; 165: 1551–1556.Ichikado K., Suga M., Muller N.L. et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am. J. Respir. Crit. Care Med. 2002; 165: 1551–1556.Primack S.L., Hartman T.E., Ikezoe J. et al. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993; 188: 817–820.Primack S.L., Hartman T.E., Ikezoe J. et al. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993; 188: 817–820.Johkoh T., Muller N.L., Taniguchi H. et al. Acute interstitial pneumonia: thin-section CT findings in 36 patients. Radiology 1999; 211: 859–863.Johkoh T., Muller N.L., Taniguchi H. et al. Acute interstitial pneumonia: thin-section CT findings in 36 patients. Radiology 1999; 211: 859–863.Desai S.R., Wells A.U., Rubens M.B. et al. Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210: 29–35.Desai S.R., Wells A.U., Rubens M.B. et al. Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210: 29–35.Ichikado K., Suga M., Muranaka H. et al. Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 2006; 238: 321–329.Ichikado K., Suga M., Muranaka H. et al. Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 2006; 238: 321–329.Araya J., Kawabata Y., Jinho P. et al. Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? Respirology 2008; 13: 408–412.Araya J., Kawabata Y., Jinho P. et al. Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? Respirology 2008; 13: 408–412.Rice A.J., Wells A.U., Bouros D. et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am. J. Clin. Pathol. 2003; 119: 709–714.Rice A.J., Wells A.U., Bouros D. et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am. J. Clin. Pathol. 2003; 119: 709–714.Song J.W., Hong S.B., Lim C.M. et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur. Respir. J. 2011; 37: 356–363.Song J.W., Hong S.B., Lim C.M. et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur. Respir. J. 2011; 37: 356–363.Agarwal R., Jindal S.K. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur. J. Intern. Med. 2008; 19: 227–235.Agarwal R., Jindal S.K. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur. J. Intern. Med. 2008; 19: 227–235.Silva C.I.S., Muller N.L., Fujimoto K. et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J. Thorac. Imag. 2007; 22: 221–229.Silva C.I.S., Muller N.L., Fujimoto K. et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J. Thorac. Imag. 2007; 22: 221–229.Churg A., Muller N.L., Silva C.I.S., Wright J.L. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am. J. Surg. Pathol. 2007; 31: 277–284.Churg A., Muller N.L., Silva C.I.S., Wright J.L. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am. J. Surg. Pathol. 2007; 31: 277–284.Suda T., Kaida Y., Nakamura Y. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir. Med. 2009; 103: 846–853.Suda T., Kaida Y., Nakamura Y. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir. Med. 2009; 103: 846–853.Park I.N., Kim D.S., Shim T.S. et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214–220.Park I.N., Kim D.S., Shim T.S. et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214–220.Miyazaki Y., Tateishi T., Akashi T. et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008; 134: 1265–1270.Miyazaki Y., Tateishi T., Akashi T. et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008; 134: 1265–1270.Collard H.R., Moore B.B., Flaherty K.R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 636–643.Collard H.R., Moore B.B., Flaherty K.R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 636–643.Akira M., Kozuka T., Yamamoto S., Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 372–378.Akira M., Kozuka T., Yamamoto S., Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 372–378.Akira M., Hamada H., Sakatani M. et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am. J. Roentgenol. 1997; 168: 79–83.Akira M., Hamada H., Sakatani M. et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am. J. Roentgenol. 1997; 168: 79–83.Fujimoto K., Taniguchi H., Johkoh T. et al. Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur. Radiol. 2012; 22: 83–92.Fujimoto K., Taniguchi H., Johkoh T. et al. Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur. Radiol. 2012; 22: 83–92.Cha S.I., Fessler M.B., Cool C.D. et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur. Respir. J. 2006; 28: 364–369.Cha S.I., Fessler M.B., Cool C.D. et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur. Respir. J. 2006; 28: 364–369.Johkoh T., Muller N.L., Pickford H.A. et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212: 567–572.Johkoh T., Muller N.L., Pickford H.A. et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212: 567–572.Reddy T.L., Tominaga M., Hansell D.M. et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur. Respir. J. 2012; 40: 377–385.Reddy T.L., Tominaga M., Hansell D.M. et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur. Respir. J. 2012; 40: 377–385.Becker C.D., Gil J., Padilla M.L. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod. Pathol. 2008; 21: 784–787.Becker C.D., Gil J., Padilla M.L. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod. Pathol. 2008; 21: 784–787.Frankel S.K., Cool C.D., Lynch D.A., Brown K.K. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007–2013.Frankel S.K., Cool C.D., Lynch D.A., Brown K.K. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007–2013.von der Thusen J.H., Hansell D.M., Tominaga M. et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod. Pathol. 2011; 24: 1633–1639.von der Thusen J.H., Hansell D.M., Tominaga M. et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod. Pathol. 2011; 24: 1633–1639.Amitani R., Niimi A., Kuze F. Idiopathic pulmonary upper lobe fibrosis (IPUF) [in Japanese]. Kokyu 1992; 11: 693–699.Amitani R., Niimi A., Kuze F. Idiopathic pulmonary upper lobe fibrosis (IPUF) [in Japanese]. Kokyu 1992; 11: 693–699.Watanabe K., Nagata N., Kitasato Y. et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir. Invest. 2012; 50: 88–97.Watanabe K., Nagata N., Kitasato Y. et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir. Invest. 2012; 50: 88–97.Beasley M.B., Franks T.J., Galvin J.R. et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch. Pathol. Lab. Med. 2002; 126: 1064–1070.Beasley M.B., Franks T.J., Galvin J.R. et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch. Pathol. Lab. Med. 2002; 126: 1064–1070.Balduin R., Giacometti C., Saccarola L. et al. Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease "stigma". Sarcoidos. Vasc. Diffuse Lung Dis. 2007; 24: 78–80.Balduin R., Giacometti C., Saccarola L. et al. Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease "stigma". Sarcoidos. Vasc. Diffuse Lung Dis. 2007; 24: 78–80.Hariri L.P., Mino&Kenudson M., Shea B. et al. Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum. Pathol. 2012; 43: 660–668.Hariri L.P., Mino&Kenudson M., Shea B. et al. Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum. Pathol. 2012; 43: 660–668.Yokogawa N., Alcid D.V. Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction. AIDS 2007; 21: 2116–2117.Yokogawa N., Alcid D.V. Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction. AIDS 2007; 21: 2116–2117.Churg A., Myers J., Suarez T. et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am. J. Surg. Pathol. 2004; 28: 62–68.Churg A., Myers J., Suarez T. et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am. J. Surg. Pathol. 2004; 28: 62–68.Fukuoka J., Franks T.J., Colby T.V. et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am. J. Surg. Pathol. 2005; 29: 948–954.Fukuoka J., Franks T.J., Colby T.V. et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am. J. Surg. Pathol. 2005; 29: 948–954.Yousem S.A., Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod. Pathol. 2002; 15: 1148–1153.Yousem S.A., Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod. Pathol. 2002; 15: 1148–1153.Mark E.J., Ruangchira Urai R. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann. Diagn. Pathol. 2008; 12: 171–180.Mark E.J., Ruangchira Urai R. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann. Diagn. Pathol. 2008; 12: 171–180.Ryerson C.J., Urbania T.H., Richeldi L. et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 2013; 42: 750–757.Ryerson C.J., Urbania T.H., Richeldi L. et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 2013; 42: 750–757.Kinder B.W., Brown K.K., McCormack F.X. et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009; 135: 1557–1563.Kinder B.W., Brown K.K., McCormack F.X. et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009; 135: 1557–1563.Satoh H., Kurishima K., Ishikawa H., Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J. Intern. Med. 2006; 260: 429–434.Satoh H., Kurishima K., Ishikawa H., Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J. Intern. Med. 2006; 260: 429–434.Prasse A., Probst C., Bargagli E. et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 717–723.Prasse A., Probst C., Bargagli E. et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 717–723.Prasse A., Pechkovsky D.V., Toews G.B. et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthr. and Rheum. 2007; 56: 1685–1693.Prasse A., Pechkovsky D.V., Toews G.B. et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthr. and Rheum. 2007; 56: 1685–1693.Ishii H., Mukae H., Kadota J. et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003; 58: 52–57.Ishii H., Mukae H., Kadota J. et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003; 58: 52–57.Ohnishi H., Yokoyama A., Kondo K. et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 2002; 165: 378–381.Ohnishi H., Yokoyama A., Kondo K. et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 2002; 165: 378–381.Casoni G.L., Ulivi P., Mercatali L. et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int. J. Biol. Markers 2010; 25: 229–235.Casoni G.L., Ulivi P., Mercatali L. et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int. J. Biol. Markers 2010; 25: 229–235.Pignatti P., Brunetti G., Moretto D. et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 173: 310–317.Pignatti P., Brunetti G., Moretto D. et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 173: 310–317.Ishii H., Mukae H., Kadota J. et al. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Respiration 2005; 72: 39–45.Ishii H., Mukae H., Kadota J. et al. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Respiration 2005; 72: 39–45.Choi E.S., Pierce E.M., Jakubzick C. et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J. Clin. Pathol. 2006; 59: 28–39.Choi E.S., Pierce E.M., Jakubzick C. et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J. Clin. Pathol. 2006; 59: 28–39.Choi E.S., Jakubzick C., Carpenter K.J. et al. Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2004; 170: 508–515.Choi E.S., Jakubzick C., Carpenter K.J. et al. Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2004; 170: 508–515.Yang I.V., Burch L.H., Steele M.P. et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175: 45–54.Yang I.V., Burch L.H., Steele M.P. et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175: 45–54.Lawson W.E., Grant S.W., Ambrosini V. et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59: 977–980.Lawson W.E., Grant S.W., Ambrosini V. et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59: 977–980.Kim K.K., Flaherty K.R., Long Q. et al. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol. Med. 2003; 9: 52–56.Kim K.K., Flaherty K.R., Long Q. et al. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol. Med. 2003; 9: 52–56.Markart P., Ruppert C., Wygrecka M. et al. Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias. Eur. Respir. J. 2007; 29: 134–137.Markart P., Ruppert C., Wygrecka M. et al. Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias. Eur. Respir. J. 2007; 29: 134–137.Zorzetto M., Ferrarotti I., Campo I. et al. NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2005; 22: 180–185.Zorzetto M., Ferrarotti I., Campo I. et al. NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2005; 22: 180–185.Hutyrova B., Pantelidis P., Drabek J. et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002; 165: 148–151.Hutyrova B., Pantelidis P., Drabek J. et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002; 165: 148–151.Renzoni E., Lympany P., Sestini P. et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthr. and Rheum. 2000; 43: 1633–1640.Renzoni E., Lympany P., Sestini P. et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthr. and Rheum. 2000; 43: 1633–1640.Zorzetto M., Ferrarotti I., Trisolini R. et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 330–334.Zorzetto M., Ferrarotti I., Trisolini R. et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 330–334.Hodgson U., Tukiainen P., Laitinen T. The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respir. Med. 2005; 99: 265–267.Hodgson U., Tukiainen P., Laitinen T. The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respir. Med. 2005; 99: 265–267.Kubistova Z., Mrazek F., Lympany P.A. et al. The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens 2008; 72: 483–486.Kubistova Z., Mrazek F., Lympany P.A. et al. The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens 2008; 72: 483–486.Mushiroda T., Wattanapokayakit S., Takahashi A. et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 2008; 45: 654–656.Mushiroda T., Wattanapokayakit S., Takahashi A. et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 2008; 45: 654–656.Selman M., Lin H.&M., Montaño M. et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum. Genet. 2003; 113: 542-550.Selman M., Lin H.&M., Montaño M. et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum. Genet. 2003; 113: 542-550.Falfán&Valencia R., Camarena A., Juárez A. et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum. Genet. 2005; 118: 235–244.Falfán&Valencia R., Camarena A., Juárez A. et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum. Genet. 2005; 118: 235–244.Checa M., Ruiz V., Montaño M. et al. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 2008; 124: 465–472.Checa M., Ruiz V., Montaño M. et al. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 2008; 124: 465–472.Matsushima H., Takayanagi N., Sakamoto T. et al. Pathologic findings both before and after steroid therapy in a case of desquamative interstitial pneumonia [article in Japanese]. Nihon Kokyuki Gakkai Zasshi 2001; 39: 609–614.Matsushima H., Takayanagi N., Sakamoto T. et al. Pathologic findings both before and after steroid therapy in a case of desquamative interstitial pneumonia [article in Japanese]. Nihon Kokyuki Gakkai Zasshi 2001; 39: 609–614.Latsi P.I., du Bois R.M., Nicholson A.G. et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med.2003; 168: 531–537.Latsi P.I., du Bois R.M., Nicholson A.G. et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med.2003; 168: 531–537.Takahashi H., Fujishima T., Koba H. et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 2000; 162: 1109–1114.Takahashi H., Fujishima T., Koba H. et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 2000; 162: 1109–1114.Greene K.E., King T.E., Kuroki Y. et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 2002; 19: 439–446.Greene K.E., King T.E., Kuroki Y. et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 2002; 19: 439–446.Yokoyama A., Kondo K., Nakajima M. et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164–168.Yokoyama A., Kondo K., Nakajima M. et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164–168.Takahashi H., Shiratori M., Kanai A. et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11: S51–S54.Takahashi H., Shiratori M., Kanai A. et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11: S51–S54.Daniil Z.D., Papageorgiou E., Koutsokera A. et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2008; 21: 26–31.Daniil Z.D., Papageorgiou E., Koutsokera A. et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2008; 21: 26–31.Rosas I.O., Richards T.J., Konishi K. et al. MMP1 and MMP7 as American Thoracic Society Documents 747 potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008; 5: e93.Rosas I.O., Richards T.J., Konishi K. et al. MMP1 and MMP7 as American Thoracic Society Documents 747 potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008; 5: e93.Gilani S.R., Vuga L.J., Lindell K.O. et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010; 5: e8959.Gilani S.R., Vuga L.J., Lindell K.O. et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010; 5: e8959.Richards T.J., Kaminski N., Baribaud F. et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: 67–76.Richards T.J., Kaminski N., Baribaud F. et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: 67–76.McKeown S., Richter A.G., O'Kane C. et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009; 33: 77–84.McKeown S., Richter A.G., O'Kane C. et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009; 33: 77–84.Shinoda H., Tasaka S., Fujishima S. et al. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 2009; 78: 285–292.Shinoda H., Tasaka S., Fujishima S. et al. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 2009; 78: 285–292.Richter A.G., McKeown S., Rathinam S. et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009; 64: 156–161.Richter A.G., McKeown S., Rathinam S. et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009; 64: 156–161.

The authors declare that there are no conflicts of interest present.